MSH2
| Symbol | – |
|---|---|
| HGNC ID | – |
| Alternative symbols | – |
| Entrez Gene | – |
| OMIM | – |
| RefSeq | – |
| UniProt | – |
| Chromosome | – |
| Locus supplementary data | – |
MSH2 is a gene in humans that encodes the MSH2 protein, which is crucial for DNA repair mechanisms, specifically in the process known as Mismatch Repair (MMR). The MSH2 protein forms heterodimers with other proteins in the MMR family, such as MSH6 or MSH3, to form complexes that recognize and repair base-base mismatches and insertion-deletion loops in DNA.
Function[edit]
The primary role of the MSH2 protein is to maintain the integrity of the genetic material by correcting errors that can occur during DNA replication. These errors, if not corrected, can lead to mutations, which in turn can cause cancer. The MSH2 protein, by forming complexes with other MMR proteins, initiates the repair process upon recognizing a mismatch in the DNA.
Clinical Significance[edit]
Mutations in the MSH2 gene are associated with Lynch syndrome, a hereditary condition that significantly increases the risk of developing colorectal cancer as well as other types of cancers including endometrial, ovarian, gastric, and urinary tract cancers. Individuals with defective MSH2 gene have a higher likelihood of accumulating mutations throughout the genome, leading to tumor development.
Genetic Testing[edit]
Genetic testing for mutations in the MSH2 gene can be crucial for families with a history of Lynch syndrome. Identifying carriers of MSH2 mutations can lead to increased surveillance and preventive measures, potentially reducing the risk of cancer development.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian